Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

NCT01711593 is registered in ClinicalTrials.gov with Andrew D. Luster, M.D.,Ph.D. as lead sponsor.

NCT NCT01711593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01711593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma
Lead sponsor
Andrew D. Luster, M.D.,Ph.D.
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2016
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergies, asthma